NCT05942404

Brief Summary

Cognitive impairment has been reported up to 54 % after colorectal surgeries. Mechanical bowel cleansing means that a system called the second brain in the body, which includes a wide variety of genetic and neuronal structures, is damaged. 100 trillion microorganisms live in the human body. The largest contact area with the external environment in the body, is the gastrointestinal mucosa. Microorganisms in the gut contain 100 times more genes than the human genome. The GI mucosa contains more than 500 million neurons called the enteric nervous system. MBP is an application that disrupts the microbiota structure and causes dehydration and electrolyte imbalance. While the most serious indication for MBP is seen as infection and health of anastomosis, recent studies say that this is not the case, even that the deterioration of the microbiota content damages the mucosal barrier, predisposes to inflammation with the removal of beneficial microorganisms and impairs wound healing. 84 patients will be included in the study, divided into two groups. In each group, blood will be drawn to measure the levels of biomarkers determined before surgery and bowel cleansing, on the 15th postoperative day and on the 90th day. Simultaneously, psychometric tests will be performed to assess cognitive impairment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

October 22, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2024

Completed
Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

9 months

First QC Date

June 14, 2023

Last Update Submit

March 4, 2026

Conditions

Keywords

POCDTAU PROTEİNBDNFLBP

Outcome Measures

Primary Outcomes (1)

  • the incidence of postoperative cognitive disfunction

    1st day before the operation, 15th day and 90th day after the operation the psychometric tests will be performed to evaluate POCD relevant biomarkers will also be measured

    3

Study Arms (2)

Group of no bowel preparation

NO INTERVENTION

none mechanical bowel preparation

Group of bowel preparation

ACTIVE COMPARATOR

mechanical bowel preparation

Procedure: mechanical bowel preparation

Interventions

mechanical bowel preparation before surgery

Group of bowel preparation

Eligibility Criteria

Age45 Years - 80 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who agreed to participate in the study
  • Patients undergoing elective colorectal surgery
  • Patients who can read and write
  • Patients whose hearing and sight are suitable for communication
  • Patients whose general sociocultural status is sufficient to perform psychometric tests.

You may not qualify if:

  • Patients with inflammatory bowel
  • Patients with cerebrovascular disease
  • Patients who require emergency surgery
  • Patients who have had repetitive surgeries
  • Patients with neurodegenerative disease
  • Patients with severe and moderate dementia (MoCA test score 21 and below)
  • Patients with a mini mental test below 24
  • Patients with severe hearing and vision impairment
  • Patients using antibiotics and probiotics
  • Patients who take long-term steroid therapy (7 days or more)
  • Patients receiving immunosuppressive therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes University

Melikgazi, Kayseri, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Postoperative Cognitive ComplicationsFrontotemporal Dementia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental DisordersFrontotemporal Lobar DegenerationDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTDP-43 ProteinopathiesNeurodegenerative DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PROFESSOR DR

Study Record Dates

First Submitted

June 14, 2023

First Posted

July 12, 2023

Study Start

October 22, 2023

Primary Completion

July 21, 2024

Study Completion

July 21, 2024

Last Updated

March 6, 2026

Record last verified: 2026-03

Locations